Dr. Daniel Goldstein reviews the STItCH trial, the largest randomized clinical trial for high-risk cardiac surgery. He also reviews the Impella Protected Cardiac Surgery Trial (IMPACT), which includes preemptive Impella 5.5 in patients undergoing high-risk cardiac surgery.

You must be logged in to view this content


Log in Sign up